Tag: MS research
-
My favorite tales (as inspiration)
I sometimes forget that multiple sclerosis is a serious disease.
-
Too old for Gilenya?
This article concludes that all DMT drugs that work on MS begin to decrease in efficacy after the age of 53.
-
Genial Gilenya®️
I am now taking the oral medication Gilenya (fingolimod). I call it genial because compared to giving myself daily shots, it is just a daily pill. But “genial” by no means suggests benign.
-
Caustic Copaxone®️
My liver toxicity from Avonex meant that I couldn’t take anything else with interferon, ruling out all other MS drugs at the time, except for one: Copaxone.
-
MS or gout
Obviously I’m not a scientist. But clearly, I think the relationship between uric acid and brain inflammation should continue to interest scientists.
-
1M U.S. MSers
When I got the same answer that they had been giving for years: that there were approx. 400,000 people in the US living with it, I knew that wasn’t correct. Does’t everybody know at least someone afflicted with this disease?
-
Lorna’s brief history of the ADA
As an MSer, I feel like I’m kinda late to the party with regards to understanding how important the ADA is. I was diagnosed in 1991 but didn’t really experience physical disability until later in my life. Why I care The NMSS says “The ADA covers almost everyone with MS — not only people […]
-
MS and the DMTs
There still is no way to definitively diagnose and no cure but there are now more than 15 drugs to try to halt progression, sometimes called disease-modifying therapies or treatments, DMTs.
-
Hello? MS is still here
It’s March 2018. MS is still here. So I’m introducing it again in case you all forgot.
-
The biotin protocol
The protocol, created by the company MedDay Pharmaceuticals in France, tests high-doses of the vitamin Biotin. The trial aims to prove that high-dose biotin can reverse disability in non-active progressive MS.